Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HEXBIO Probiotic in Overweight and Obese Saudi Adults
NCT05667038Phase 3Completed
- Sponsor
- King Saud University
- Start
- Mar 2022
- Primary completion
- Aug 2023
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in obesity, sponsored by King Saud University. Primary endpoint: waist circumference at 12 weeks. Started Mar 2022; status: completed.
02
Conditions
obesity
Beyond the preview
Go deeper on NCT05667038.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05667038.